Skip to main content

VivoSense

By Jessica Hagen | 11:17 am | November 29, 2022
The company will use the investment to expand its product specialist and client engagement teams.
By Laura Lovett | 03:44 pm | March 30, 2022
Others receiving capital infusions include Altoida, which adds $14 million to its Series A round, and Zephyr AI, which rakes in $18.5 million. 
By Dave Muoio and Laura Lovett | 04:24 pm | May 28, 2019
Also: ActiGraph and VivoSense partner on wearables for drug trials; AristaMD adds Corstrata wound and ostomy specialists to remote consultation service.